✦ LIBER ✦

103High dose rate intracavitary brachytherapy following external beam radiotherapy for esophageal cancer

✍ Scribed by Takashi Fujii; Masashi Kawamura; Masaaki Kataoka; Takashi Ochi; Akira Fukui; Junpei Ikezoe

Book ID: 119522281
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 124 KB
Volume: 47
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(98)80108-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1397 POSTER Optimal dose and fractionati

1397 POSTER Optimal dose and fractionation for combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Esophageal ulceration following high-dos

Esophageal ulceration following high-dose-rate intraluminal brachytherapy for esophageal cancer

✍ Hishikawa, Yoshio; Izumi, Masayuki; Kurisu, Koichi; Taniguchi, Midori; Kamikonya 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 264 KB

48 oral Cervical cancer: timing of high-

48 oral Cervical cancer: timing of high-dose rate brachytherapy with external beam radiotherapy

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 146 KB

External beam radiotherapy with high dos

External beam radiotherapy with high dose rate (HDR) brachytherapy boost in localised prostate cancer

✍ L. Åström; D. Pedersen; S. Holmäng 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Isolated Vaginal Recurrences in Endometr

Isolated Vaginal Recurrences in Endometrial Carcinoma: Treatment Results Using High-Dose-Rate Intracavitary Brachytherapy and External Beam Radiotherapy

✍ Howard H. Pai; Luis Souhami; Brenda G. Clark; Ted Roman 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Adjuvant fractionated high-dose-rate int

Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma

✍ Jiade J. Lu; Thomas P. Shakespeare; Luke Kim Siang Tan; Boon Cher Goh; Jay S. Co 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract ## Background. The value of high‐dose‐rate intracavitary brachytherapy (HDRIB) for persistent or recurrent nasopharyngeal carcinoma has been well described; however, the benefit of routine adjuvant fractionated HDRIB following external beam radiation therapy (EBRT) has not been complet